Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne
This study has been completed.
Study NCT00713609   Information provided by GlaxoSmithKline

First Received on July 7, 2008.   Last Updated on February 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acne Vulgaris
More general conditions related to this trial
Acneiform Eruptions
Facial Dermatoses
Sebaceous Gland Diseases
Skin Diseases
Interventions listed in this trial
Clindamycin gel + tazarotene cream
Vehicle gel+ tazarotene cream
Vehicle gel + vehicle cream
Additional drug interventions recognized in this trial
Benzoyl Peroxide
Clindamycin
Clindamycin-2-phosphate
Nicotinic Acids
Tazarotene
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Dermatologic Agents
Enzyme Inhibitors
Growth Substances
Keratolytic Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Synthesis Inhibitors
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Stiefel, a GSK Company
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services